Increased monocyte count as a cellular biomarker for poor outcomes in fibrotic diseases: a retrospective, multicentre cohort study
Madeleine Scott(Stanford Medicine), Purvesh Khatri, Jose D. Herazo‐Maya(University of South Florida), Francesco Vallania(Stanford Medicine), Jessika Baral(Stanford University), Kathleen Aren(Northwestern University), Mary Carns(Northwestern University), Shirley Chen(Stanford Medicine), Bethany B. Moore(Michigan Medicine), Erica L. Herzog(Yale University), Katie Quinn(Stanford University), Robert J. Carroll(Vanderbilt University), Nigam H. Shah(Stanford University), Hayley Warsinske(University of Michigan–Ann Arbor), Monique Hinchcliff(Yale University), Joshua C. Denny(Vanderbilt University), Kimberly Koloms(Northwestern University), Hongyu Zhao(Yale University), Naftali Kaminski(Yale University), Qin Li(Yale University), Fernando J. Martínez(University of Michigan–Ann Arbor), Jonathan A. Kropski(Pulmonary and Allergy Associates), Jungwha Lee(Northwestern University), Jiehuan Sun(Yale University)
Cited by 249
Related Papers
Standards for the diagnosis and treatment of patients with COPD: a summary of the ATS/ERS position paper
|European Respiratory Journal|2004|4.4k
An Official American Thoracic Society/European Respiratory Society Statement: Update of the International Multidisciplinary Classification of the Idiopathic Interstitial Pneumonias
|American Journal of Respiratory and Critical Care Medicine|2013|4.3k
Diagnosis of Idiopathic Pulmonary Fibrosis. An Official ATS/ERS/JRS/ALAT Clinical Practice Guideline
|American Journal of Respiratory and Critical Care Medicine|2018|4.1k